FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4312070761> ?p ?o ?g. }

• W4312070761 abstract "Understanding the burdens and trends of non-alcoholic fatty liver disease (NAFLD) is necessary for developing effective intervention strategies. In this study, Global Burden of Disease (GBD) 2019 study data were extracted and analyzed to elucidate trends of NAFLD.The prevalence, incidence, disability-adjusted life year (DALY), and death rates of NAFLD in geographic populations worldwide from 1990 to 2019 were extracted from the GBD 2019 study data. The global temporal trend of NAFLD from 1990 to 2019 was evaluated using estimated annual percentage changes (EAPCs) and age-standardized rates.Globally, between 1999 and 2019, the age-standardized prevalence rate of NAFLD increased, with EAPCs of 0.77 [95% CI (0.69, 0.85)], whereas the DALY and Death rates decreased, with EAPCs of -0.82 [95% CI (-0.92, -0.71)], and -0.67 [95% CI (-0.76, -0.58)], respectively. Geographically, the age-standardized prevalence rate showed the most serious upward trend in high-income North America with an EAPC of 0.98 [95% CI (0.95, 1.02)], and the age-standardized incidence rate showed an upward trend in Central Asia with an EAPC of 3.17 [95% CI (2.2, 2.49)]. The most significant upward trend of DALY and death rates appeared in Eastern Europe, with EAPCs of 4.06 [95% CI (3.31, 4.82)], and 3.36 [95% CI (2.77, 3.96)], respectively. At the country level, the age-standardized rates showed an upward trend in Armenia, Belarus, and Republic of Korea. Regarding age groups, the percentage change of prevalence was the highest in the 40 to 44 group [0.29 (0.26, 0.34)] from 1990 to 2019; the percentage change of incidence was the highest in the 85 to 89 group [0.46 (0.12, 0.71)] from 1990 to 2019; the percentage change of DALY was the highest in the 80 to 84 group [0.25 (0.11, 0.39)] from 1990 to 2019; and the percentage change of death rate was the highest in the 15 to 19 group [0.36 (0.17, 0.60)] from 1990 to 2019. The percentage change of prevalence of liver cancer due to NASH was the highest in the group of 85 to 89, whereas those of incidence, DALY, and death were the highest in the group above 95 from 1990 to 2019. Regarding the sociodemographic index (SDI), the highest age-standardized prevalence, incidence, and Death rates of NAFLD occurred in middle-SDI countries, and the highest DALY rates of NAFLD occurred in low-SDI countries.Global NAFLD burdens have increased since 1990. Our findings provide a reference for policymakers to reduce the burden of NAFLD, especially in middle and low-SDI countries." @default.
• W4312070761 created "2023-01-04" @default.
• W4312070761 creator A5013518217 @default.
• W4312070761 creator A5020492948 @default.
• W4312070761 creator A5023724158 @default.
• W4312070761 creator A5031436726 @default.
• W4312070761 creator A5036248809 @default.
• W4312070761 creator A5057903850 @default.
• W4312070761 creator A5058380236 @default.
• W4312070761 creator A5069726750 @default.
• W4312070761 creator A5083816181 @default.
• W4312070761 creator A5090332606 @default.
• W4312070761 date "2022-12-21" @default.
• W4312070761 modified "2023-10-10" @default.
• W4312070761 title "Changes in the global, regional, and national burdens of NAFLD from 1990 to 2019: A systematic analysis of the global burden of disease study 2019" @default.
• W4312070761 cites W1935787683 @default.
• W4312070761 cites W1963797408 @default.
• W4312070761 cites W2028008963 @default.
• W4312070761 cites W2063437798 @default.
• W4312070761 cites W2068367315 @default.
• W4312070761 cites W2113743121 @default.
• W4312070761 cites W2161033538 @default.
• W4312070761 cites W2204688218 @default.
• W4312070761 cites W2242482860 @default.
• W4312070761 cites W2264072217 @default.
• W4312070761 cites W2301655565 @default.
• W4312070761 cites W2302013663 @default.
• W4312070761 cites W2475227269 @default.
• W4312070761 cites W2508708811 @default.
• W4312070761 cites W2588089969 @default.
• W4312070761 cites W2657296316 @default.
• W4312070761 cites W2759997926 @default.
• W4312070761 cites W2784030340 @default.
• W4312070761 cites W2793096970 @default.
• W4312070761 cites W2793966808 @default.
• W4312070761 cites W2889932786 @default.
• W4312070761 cites W2899595328 @default.
• W4312070761 cites W2905137137 @default.
• W4312070761 cites W2946006649 @default.
• W4312070761 cites W2976365725 @default.
• W4312070761 cites W2995198352 @default.
• W4312070761 cites W3012883032 @default.
• W4312070761 cites W3047044606 @default.
• W4312070761 cites W3084955164 @default.
• W4312070761 cites W3092849554 @default.
• W4312070761 cites W3092861045 @default.
• W4312070761 cites W3117083078 @default.
• W4312070761 cites W3117418828 @default.
• W4312070761 cites W3126792678 @default.
• W4312070761 cites W3165616567 @default.
• W4312070761 cites W3182277666 @default.
• W4312070761 cites W3186380763 @default.
• W4312070761 cites W3197233575 @default.
• W4312070761 cites W3199671553 @default.
• W4312070761 cites W4211133889 @default.
• W4312070761 cites W4214920829 @default.
• W4312070761 cites W4220659089 @default.
• W4312070761 cites W4226106938 @default.
• W4312070761 cites W4283696448 @default.
• W4312070761 cites W4285494368 @default.
• W4312070761 doi "https://doi.org/10.3389/fnut.2022.1047129" @default.
• W4312070761 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/36618688" @default.
• W4312070761 hasPublicationYear "2022" @default.
• W4312070761 type Work @default.
• W4312070761 citedByCount "8" @default.
• W4312070761 countsByYear W43120707612023 @default.
• W4312070761 crossrefType "journal-article" @default.
• W4312070761 hasAuthorship W4312070761A5013518217 @default.
• W4312070761 hasAuthorship W4312070761A5020492948 @default.
• W4312070761 hasAuthorship W4312070761A5023724158 @default.
• W4312070761 hasAuthorship W4312070761A5031436726 @default.
• W4312070761 hasAuthorship W4312070761A5036248809 @default.
• W4312070761 hasAuthorship W4312070761A5057903850 @default.
• W4312070761 hasAuthorship W4312070761A5058380236 @default.
• W4312070761 hasAuthorship W4312070761A5069726750 @default.
• W4312070761 hasAuthorship W4312070761A5083816181 @default.
• W4312070761 hasAuthorship W4312070761A5090332606 @default.
• W4312070761 hasBestOaLocation W43120707611 @default.
• W4312070761 hasConcept C120665830 @default.
• W4312070761 hasConcept C121332964 @default.
• W4312070761 hasConcept C126322002 @default.
• W4312070761 hasConcept C144024400 @default.
• W4312070761 hasConcept C149923435 @default.
• W4312070761 hasConcept C179755657 @default.
• W4312070761 hasConcept C2778772119 @default.
• W4312070761 hasConcept C2779134260 @default.
• W4312070761 hasConcept C2780664029 @default.
• W4312070761 hasConcept C3020448403 @default.
• W4312070761 hasConcept C511355011 @default.
• W4312070761 hasConcept C61511704 @default.
• W4312070761 hasConcept C71924100 @default.
• W4312070761 hasConceptScore W4312070761C120665830 @default.
• W4312070761 hasConceptScore W4312070761C121332964 @default.
• W4312070761 hasConceptScore W4312070761C126322002 @default.
• W4312070761 hasConceptScore W4312070761C144024400 @default.
• W4312070761 hasConceptScore W4312070761C149923435 @default.
• W4312070761 hasConceptScore W4312070761C179755657 @default.
• W4312070761 hasConceptScore W4312070761C2778772119 @default.
• W4312070761 hasConceptScore W4312070761C2779134260 @default.
• W4312070761 hasConceptScore W4312070761C2780664029 @default.

• next